Showing results (191-200 of 204) with videos related to

Sort By:
Pageof 21
Biorxiv : the Preprint Server for Biology|July 15, 2025
Computer prediction and genetic analysis identifies retinoic acid modulation as a driver of conserved longevity pathways in genetically-diverse Caenorhabditis nematodesStephen A Banse, Christine A Sedore, Anna L Coleman-Hulbert, et al.
Journal of the National Cancer Institute|December 29, 2020
Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology GroupHe Li, Saumya D Sisoudiya, Bailey A Martin-Giacalone, et al.
Journal of the National Cancer Institute|March 23, 2023
Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children's Oncology GroupBailey A Martin-Giacalone, Melissa A Richard, Michael E Scheurer, et al.
JCO Precision Oncology|June 7, 2021
Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With RhabdomyosarcomaJung Kim, Nicholas Light, Vallijah Subasri, et al.
HGG Advances|June 11, 2025
The Impact of Genetic Ancestry on Survival Outcomes in Pediatric Rhabdomyosarcoma: A Report from the Children's Oncology GroupEkene A Onwuka, Christina L Magyar, Bailey A Martin-Giacalone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2022
Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology GroupDavid Milewski, Hyun Jung, G Thomas Brown, et al.
JCO Clinical Cancer Informatics|November 13, 2023
Osteosarcoma Explorer: A Data Commons With Clinical, Genomic, Protein, and Tissue Imaging Data for Osteosarcoma ResearchDonghan M Yang, Qinbo Zhou, Lauren Furman-Cline, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Collin D Heer, et al.
JAMA Network Open|March 28, 2024
Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology GroupBailey A Martin-Giacalone, He Li, Michael E Scheurer, et al.
Molecular Cancer Therapeutics|April 22, 2026
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Shahyan Rehman, et al.
Pageof 21